Loading…
Prevalence of Measles Antibodies in Asymptomatic Human Immunodeficiency Virus-Infected Adults
One hundred five asymptomatic human immunodeficiency virus-seropositive adults were screened for measles antibody. Ages ranged from 21 to 59 years (mean, 35.7). CD4+ lymphocyte counts (range, 76–1137/mm3 ) , percentage of CD4+ cells (6–42), CD4:CD8 ratio (0.08–.3), measles antibody titers by EIA, an...
Saved in:
Published in: | The Journal of infectious diseases 1991-11, Vol.164 (5), p.973-975 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c383t-6229cacd581025f16f62b2f436754f0b0d018830c69c2973d99aa9f136a213a13 |
---|---|
cites | |
container_end_page | 975 |
container_issue | 5 |
container_start_page | 973 |
container_title | The Journal of infectious diseases |
container_volume | 164 |
creator | Sha, Beverly E. Harris, Alan A. Benson, Constance A. Atkinson, William L. Urbanski, Pamela A. Stewart, John A. Williams, Walter W. Murphy, Robert L. Phair, John P. Levin, Stuart A. Kessler, Harold A. |
description | One hundred five asymptomatic human immunodeficiency virus-seropositive adults were screened for measles antibody. Ages ranged from 21 to 59 years (mean, 35.7). CD4+ lymphocyte counts (range, 76–1137/mm3 ) , percentage of CD4+ cells (6–42), CD4:CD8 ratio (0.08–.3), measles antibody titers by EIA, and undocumented history of prior measles or immunization were obtained. Forty-six patients gave a history of measles but no immunization, 18 ofimmunization but no measles, 26 of immunization and measles, and 15 of neither measles nor vaccination. Only one patient |
doi_str_mv | 10.1093/infdis/164.5.973 |
format | article |
fullrecord | <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_72451691</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>30112014</jstor_id><sourcerecordid>30112014</sourcerecordid><originalsourceid>FETCH-LOGICAL-c383t-6229cacd581025f16f62b2f436754f0b0d018830c69c2973d99aa9f136a213a13</originalsourceid><addsrcrecordid>eNpFkM1vEzEQxS0EKmnhzgVpD4jbpmN77V0fQwVNRBA9AEKVkOX4Q3LZ9aa2FzX_PY42hNNY-r33ZvwQeoNhiUHQax-c8eka82bJlqKlz9ACM9rWnGP6HC0ACKlxJ8RLdJnSAwA0lLcX6ALzjlDBFujXXbR_VG-DttXoqi9Wpd6mahWy343Gl6cP1Sodhn0eB5W9rtbToEK1GYYpjMY6r30xH6ofPk6p3gRndbamWpmpz-kVeuFUn-zr07xC3z99_Hazrrdfbzc3q22taUdzzQkRWmnDOgyEOcwdJzvijreyxsEODOCuo6C50KT80gihlHCYckUwVZheofdz7j6Oj5NNWQ4-adv3KthxSrIlDcNcHIUwC3UcU4rWyX30g4oHiUEeG5Vzo7I0Kpksu4rl7Sl72g3W_DfMFRb-7sRV0qp3UQVdAv7JGHB2DD7HPKQ8xjOmgDEB3BRez9ynbJ_OXMXfkre0ZXL9817e37YfPtMtyDv6F0sbmEM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72451691</pqid></control><display><type>article</type><title>Prevalence of Measles Antibodies in Asymptomatic Human Immunodeficiency Virus-Infected Adults</title><source>JSTOR Archival Journals and Primary Sources Collection【Remote access available】</source><source>Oxford University Press:Jisc Collections:Oxford Journal Archive: Access period 2024-2025</source><creator>Sha, Beverly E. ; Harris, Alan A. ; Benson, Constance A. ; Atkinson, William L. ; Urbanski, Pamela A. ; Stewart, John A. ; Williams, Walter W. ; Murphy, Robert L. ; Phair, John P. ; Levin, Stuart A. ; Kessler, Harold A.</creator><creatorcontrib>Sha, Beverly E. ; Harris, Alan A. ; Benson, Constance A. ; Atkinson, William L. ; Urbanski, Pamela A. ; Stewart, John A. ; Williams, Walter W. ; Murphy, Robert L. ; Phair, John P. ; Levin, Stuart A. ; Kessler, Harold A.</creatorcontrib><description>One hundred five asymptomatic human immunodeficiency virus-seropositive adults were screened for measles antibody. Ages ranged from 21 to 59 years (mean, 35.7). CD4+ lymphocyte counts (range, 76–1137/mm3 ) , percentage of CD4+ cells (6–42), CD4:CD8 ratio (0.08–.3), measles antibody titers by EIA, and undocumented history of prior measles or immunization were obtained. Forty-six patients gave a history of measles but no immunization, 18 ofimmunization but no measles, 26 of immunization and measles, and 15 of neither measles nor vaccination. Only one patient <1%) lacked levels of antibody considered protective, Neither the presence nor the level of antibody were predictable from patient age, history of measles or immunization, CD4+ lymphocyte count, percentage of CD4+ cells, or CD4:CD8 ratio. Nearly all subjects had antibody to measles, regardless of immunization or measles history. Whether these antibodies are truly protective is unknown.</description><identifier>ISSN: 0022-1899</identifier><identifier>EISSN: 1537-6613</identifier><identifier>DOI: 10.1093/infdis/164.5.973</identifier><identifier>PMID: 1682395</identifier><identifier>CODEN: JIDIAQ</identifier><language>eng</language><publisher>Chicago, IL: The University of Chicago Press</publisher><subject>Adult ; AIDS/HIV ; Antibodies ; Antibodies, Viral - blood ; Biological and medical sciences ; CD4-Positive T-Lymphocytes ; Chicago - epidemiology ; Children ; Concise Communications ; Disease Susceptibility ; Female ; HIV Infections - complications ; Humans ; Immunization ; Immunodeficiencies ; Immunodeficiencies. Immunoglobulinopathies ; Immunopathology ; Leukocyte Count ; Lymphocytes ; Male ; Measles ; Measles - complications ; Measles - epidemiology ; Measles - immunology ; Measles Vaccine - immunology ; Measles virus - immunology ; Medical sciences ; Middle Aged ; Notifiable diseases ; Patient medical history ; Percentages ; Prevalence ; Surveys and Questionnaires ; Vaccination ; Viruses</subject><ispartof>The Journal of infectious diseases, 1991-11, Vol.164 (5), p.973-975</ispartof><rights>Copyright 1991 The University of Chicago</rights><rights>1992 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c383t-6229cacd581025f16f62b2f436754f0b0d018830c69c2973d99aa9f136a213a13</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/30112014$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/30112014$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,58238,58471</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=5065109$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1682395$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sha, Beverly E.</creatorcontrib><creatorcontrib>Harris, Alan A.</creatorcontrib><creatorcontrib>Benson, Constance A.</creatorcontrib><creatorcontrib>Atkinson, William L.</creatorcontrib><creatorcontrib>Urbanski, Pamela A.</creatorcontrib><creatorcontrib>Stewart, John A.</creatorcontrib><creatorcontrib>Williams, Walter W.</creatorcontrib><creatorcontrib>Murphy, Robert L.</creatorcontrib><creatorcontrib>Phair, John P.</creatorcontrib><creatorcontrib>Levin, Stuart A.</creatorcontrib><creatorcontrib>Kessler, Harold A.</creatorcontrib><title>Prevalence of Measles Antibodies in Asymptomatic Human Immunodeficiency Virus-Infected Adults</title><title>The Journal of infectious diseases</title><addtitle>J Infect Dis</addtitle><description>One hundred five asymptomatic human immunodeficiency virus-seropositive adults were screened for measles antibody. Ages ranged from 21 to 59 years (mean, 35.7). CD4+ lymphocyte counts (range, 76–1137/mm3 ) , percentage of CD4+ cells (6–42), CD4:CD8 ratio (0.08–.3), measles antibody titers by EIA, and undocumented history of prior measles or immunization were obtained. Forty-six patients gave a history of measles but no immunization, 18 ofimmunization but no measles, 26 of immunization and measles, and 15 of neither measles nor vaccination. Only one patient <1%) lacked levels of antibody considered protective, Neither the presence nor the level of antibody were predictable from patient age, history of measles or immunization, CD4+ lymphocyte count, percentage of CD4+ cells, or CD4:CD8 ratio. Nearly all subjects had antibody to measles, regardless of immunization or measles history. Whether these antibodies are truly protective is unknown.</description><subject>Adult</subject><subject>AIDS/HIV</subject><subject>Antibodies</subject><subject>Antibodies, Viral - blood</subject><subject>Biological and medical sciences</subject><subject>CD4-Positive T-Lymphocytes</subject><subject>Chicago - epidemiology</subject><subject>Children</subject><subject>Concise Communications</subject><subject>Disease Susceptibility</subject><subject>Female</subject><subject>HIV Infections - complications</subject><subject>Humans</subject><subject>Immunization</subject><subject>Immunodeficiencies</subject><subject>Immunodeficiencies. Immunoglobulinopathies</subject><subject>Immunopathology</subject><subject>Leukocyte Count</subject><subject>Lymphocytes</subject><subject>Male</subject><subject>Measles</subject><subject>Measles - complications</subject><subject>Measles - epidemiology</subject><subject>Measles - immunology</subject><subject>Measles Vaccine - immunology</subject><subject>Measles virus - immunology</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Notifiable diseases</subject><subject>Patient medical history</subject><subject>Percentages</subject><subject>Prevalence</subject><subject>Surveys and Questionnaires</subject><subject>Vaccination</subject><subject>Viruses</subject><issn>0022-1899</issn><issn>1537-6613</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><recordid>eNpFkM1vEzEQxS0EKmnhzgVpD4jbpmN77V0fQwVNRBA9AEKVkOX4Q3LZ9aa2FzX_PY42hNNY-r33ZvwQeoNhiUHQax-c8eka82bJlqKlz9ACM9rWnGP6HC0ACKlxJ8RLdJnSAwA0lLcX6ALzjlDBFujXXbR_VG-DttXoqi9Wpd6mahWy343Gl6cP1Sodhn0eB5W9rtbToEK1GYYpjMY6r30xH6ofPk6p3gRndbamWpmpz-kVeuFUn-zr07xC3z99_Hazrrdfbzc3q22taUdzzQkRWmnDOgyEOcwdJzvijreyxsEODOCuo6C50KT80gihlHCYckUwVZheofdz7j6Oj5NNWQ4-adv3KthxSrIlDcNcHIUwC3UcU4rWyX30g4oHiUEeG5Vzo7I0Kpksu4rl7Sl72g3W_DfMFRb-7sRV0qp3UQVdAv7JGHB2DD7HPKQ8xjOmgDEB3BRez9ynbJ_OXMXfkre0ZXL9817e37YfPtMtyDv6F0sbmEM</recordid><startdate>19911101</startdate><enddate>19911101</enddate><creator>Sha, Beverly E.</creator><creator>Harris, Alan A.</creator><creator>Benson, Constance A.</creator><creator>Atkinson, William L.</creator><creator>Urbanski, Pamela A.</creator><creator>Stewart, John A.</creator><creator>Williams, Walter W.</creator><creator>Murphy, Robert L.</creator><creator>Phair, John P.</creator><creator>Levin, Stuart A.</creator><creator>Kessler, Harold A.</creator><general>The University of Chicago Press</general><general>University of Chicago Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19911101</creationdate><title>Prevalence of Measles Antibodies in Asymptomatic Human Immunodeficiency Virus-Infected Adults</title><author>Sha, Beverly E. ; Harris, Alan A. ; Benson, Constance A. ; Atkinson, William L. ; Urbanski, Pamela A. ; Stewart, John A. ; Williams, Walter W. ; Murphy, Robert L. ; Phair, John P. ; Levin, Stuart A. ; Kessler, Harold A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c383t-6229cacd581025f16f62b2f436754f0b0d018830c69c2973d99aa9f136a213a13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Adult</topic><topic>AIDS/HIV</topic><topic>Antibodies</topic><topic>Antibodies, Viral - blood</topic><topic>Biological and medical sciences</topic><topic>CD4-Positive T-Lymphocytes</topic><topic>Chicago - epidemiology</topic><topic>Children</topic><topic>Concise Communications</topic><topic>Disease Susceptibility</topic><topic>Female</topic><topic>HIV Infections - complications</topic><topic>Humans</topic><topic>Immunization</topic><topic>Immunodeficiencies</topic><topic>Immunodeficiencies. Immunoglobulinopathies</topic><topic>Immunopathology</topic><topic>Leukocyte Count</topic><topic>Lymphocytes</topic><topic>Male</topic><topic>Measles</topic><topic>Measles - complications</topic><topic>Measles - epidemiology</topic><topic>Measles - immunology</topic><topic>Measles Vaccine - immunology</topic><topic>Measles virus - immunology</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Notifiable diseases</topic><topic>Patient medical history</topic><topic>Percentages</topic><topic>Prevalence</topic><topic>Surveys and Questionnaires</topic><topic>Vaccination</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sha, Beverly E.</creatorcontrib><creatorcontrib>Harris, Alan A.</creatorcontrib><creatorcontrib>Benson, Constance A.</creatorcontrib><creatorcontrib>Atkinson, William L.</creatorcontrib><creatorcontrib>Urbanski, Pamela A.</creatorcontrib><creatorcontrib>Stewart, John A.</creatorcontrib><creatorcontrib>Williams, Walter W.</creatorcontrib><creatorcontrib>Murphy, Robert L.</creatorcontrib><creatorcontrib>Phair, John P.</creatorcontrib><creatorcontrib>Levin, Stuart A.</creatorcontrib><creatorcontrib>Kessler, Harold A.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sha, Beverly E.</au><au>Harris, Alan A.</au><au>Benson, Constance A.</au><au>Atkinson, William L.</au><au>Urbanski, Pamela A.</au><au>Stewart, John A.</au><au>Williams, Walter W.</au><au>Murphy, Robert L.</au><au>Phair, John P.</au><au>Levin, Stuart A.</au><au>Kessler, Harold A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence of Measles Antibodies in Asymptomatic Human Immunodeficiency Virus-Infected Adults</atitle><jtitle>The Journal of infectious diseases</jtitle><addtitle>J Infect Dis</addtitle><date>1991-11-01</date><risdate>1991</risdate><volume>164</volume><issue>5</issue><spage>973</spage><epage>975</epage><pages>973-975</pages><issn>0022-1899</issn><eissn>1537-6613</eissn><coden>JIDIAQ</coden><abstract>One hundred five asymptomatic human immunodeficiency virus-seropositive adults were screened for measles antibody. Ages ranged from 21 to 59 years (mean, 35.7). CD4+ lymphocyte counts (range, 76–1137/mm3 ) , percentage of CD4+ cells (6–42), CD4:CD8 ratio (0.08–.3), measles antibody titers by EIA, and undocumented history of prior measles or immunization were obtained. Forty-six patients gave a history of measles but no immunization, 18 ofimmunization but no measles, 26 of immunization and measles, and 15 of neither measles nor vaccination. Only one patient <1%) lacked levels of antibody considered protective, Neither the presence nor the level of antibody were predictable from patient age, history of measles or immunization, CD4+ lymphocyte count, percentage of CD4+ cells, or CD4:CD8 ratio. Nearly all subjects had antibody to measles, regardless of immunization or measles history. Whether these antibodies are truly protective is unknown.</abstract><cop>Chicago, IL</cop><pub>The University of Chicago Press</pub><pmid>1682395</pmid><doi>10.1093/infdis/164.5.973</doi><tpages>3</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-1899 |
ispartof | The Journal of infectious diseases, 1991-11, Vol.164 (5), p.973-975 |
issn | 0022-1899 1537-6613 |
language | eng |
recordid | cdi_proquest_miscellaneous_72451691 |
source | JSTOR Archival Journals and Primary Sources Collection【Remote access available】; Oxford University Press:Jisc Collections:Oxford Journal Archive: Access period 2024-2025 |
subjects | Adult AIDS/HIV Antibodies Antibodies, Viral - blood Biological and medical sciences CD4-Positive T-Lymphocytes Chicago - epidemiology Children Concise Communications Disease Susceptibility Female HIV Infections - complications Humans Immunization Immunodeficiencies Immunodeficiencies. Immunoglobulinopathies Immunopathology Leukocyte Count Lymphocytes Male Measles Measles - complications Measles - epidemiology Measles - immunology Measles Vaccine - immunology Measles virus - immunology Medical sciences Middle Aged Notifiable diseases Patient medical history Percentages Prevalence Surveys and Questionnaires Vaccination Viruses |
title | Prevalence of Measles Antibodies in Asymptomatic Human Immunodeficiency Virus-Infected Adults |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T00%3A30%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence%20of%20Measles%20Antibodies%20in%20Asymptomatic%20Human%20Immunodeficiency%20Virus-Infected%20Adults&rft.jtitle=The%20Journal%20of%20infectious%20diseases&rft.au=Sha,%20Beverly%20E.&rft.date=1991-11-01&rft.volume=164&rft.issue=5&rft.spage=973&rft.epage=975&rft.pages=973-975&rft.issn=0022-1899&rft.eissn=1537-6613&rft.coden=JIDIAQ&rft_id=info:doi/10.1093/infdis/164.5.973&rft_dat=%3Cjstor_proqu%3E30112014%3C/jstor_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c383t-6229cacd581025f16f62b2f436754f0b0d018830c69c2973d99aa9f136a213a13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=72451691&rft_id=info:pmid/1682395&rft_jstor_id=30112014&rfr_iscdi=true |